{"title":"All","description":"\u003ch1 class=\"p1\"\u003e\n  \u003cspan class=\"s1\"\u003eAll Peptides\u003c\/span\u003e\n\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eDiscover popular peptides such as BPC-157, Retatrutide, TB-500, GHK-Cu, MOTS-c, and others.\u003c\/p\u003e","products":[{"product_id":"fgtb-500","title":"TB-500 (frag. 17-23) 10mg","description":"\u003ch1 class=\"p1\"\u003eWhat is TB-500?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eTB-500 is a synthetic version of the natural peptide thymosin beta-4, found in almost all tissues of the human body. It is composed of 43 amino acids and has been described in research models with a potential role in cell migration, angiogenesis, and tissue repair processes. In research models, TB-500 has been described with the potential to support tissue regeneration, inflammatory response, and healing processes. In research settings, it has shown effects on improving the healing of tendons, muscles, and skin.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eObservations for TB-500\u003c\/h2\u003e\n\u003cp class=\"p3\"\u003eTB-500 is being investigated for its possible effects on:\u003c\/p\u003e\n\u003cp class=\"p3\"\u003eHealing of muscle and tendon injuries – an effect on recovery processes and tissue regeneration has been observed in research models.\u003c\/p\u003e\n\u003cp class=\"p3\"\u003eStimulation of angiogenesis – an effect on the formation of new blood vessels and local blood supply has been described.\u003c\/p\u003e\n\u003cp class=\"p3\"\u003eAnti-inflammatory effect – an observed influence on inflammatory mediators and edema.\u003c\/p\u003e\n\u003cp class=\"p3\"\u003eJoint and bone health – an effect on recovery processes after injuries has been described in research settings.\u003c\/p\u003e\n\u003cp class=\"p3\"\u003eHealing of skin and connective tissue lesions – an effect on the regeneration of epithelial tissues has been observed in research models.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, subcutaneous administration of doses 2-5 mg, divided 3 times a week for 4-6 weeks, is most commonly found, after which a maintenance phase is entered.\u003c\/p\u003e\n\u003cp\u003eFor 5 mg + 3 ml bacteriostatic water: 1.67 mg\/ml → 0.3 ml = 0.5 mg\u003c\/p\u003e\n\u003cp\u003eFor 10 mg + 3 ml bacteriostatic water: 3.3 mg\/ml → 0.3 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp\u003e0.15 ml = 250 μg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 500 μg\u003c\/p\u003e\n\u003cp\u003e0.45 ml = 750 μg\u003c\/p\u003e\n\u003cp\u003e0.6 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.75 ml = 1.25 mg\u003c\/p\u003e\n\u003cp\u003eExample values for 10 mg:\u003c\/p\u003e\n\u003cp\u003e0.15 ml = 500 μg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.45 ml = 1.5 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eTB-500 has been primarily studied in preclinical models, but also in some clinical experiments.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn orthopedics, it has shown potential for improved healing of tendon and muscle tears, as well as accelerated recovery after surgery.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn cardiology, there is data on a protective effect in myocardial damage by stimulating angiogenesis and improved local blood supply.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn neurology, experiments suggest it can support the recovery of nerve cells and reduce damage after ischemic incidents.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn dermatology, faster healing of skin wounds and ulcers has been reported.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eApplication in Sports\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eTB-500 is prohibited by WADA for use by athletes, as it can:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- accelerate recovery after muscle and tendon injuries\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- improve blood supply and tissue healing\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- shorten recovery time between intense training sessions\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eReported side effects in scientific studies are rare and usually mild:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- fatigue\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- headache\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- redness or pain at the injection site\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eLess commonly, changes in appetite or drowsiness may be observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is collected and systematized from various scientific sources and studies. It is for educational purposes only and should not be used for the diagnosis, treatment, or prevention of diseases.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"10mg","offer_id":53386103914839,"sku":"PP-TB500-10MG","price":49.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/tb-500-frag-17-23br5mg10mg-2753046_00c9e91e-c9ae-4c84-8262-6832dc337d9e.png?v=1779544795"},{"product_id":"pp-thymosin-beta-4","title":"Thymosin beta-4 (Thymosin beta-4) 5mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Thymosin Beta-4?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eThymosin beta-4 is a natural peptide, composed of 43 amino acids, present in almost all human and animal tissues.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIt belongs to the family of thymosin peptides and has been described in research models with a role in cell migration, angiogenesis, inflammatory response, and restorative processes. The synthetic version of this peptide is more widely known as TB-500. Thymosin Beta-4 is particularly active in areas of tissue damage, where it stimulates cell regeneration and the formation of new blood vessels.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"p1\"\u003eThese properties are why Thymosin Beta-4 is a subject of research interest in orthopedics, cardiology, dermatology, and sports medicine.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\u003ch2\u003eObservations on Thymosin beta-4\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThymosin Beta-4 is being researched for its possible effects on:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eHealing of muscle and tendon injuries – an effect on recovery processes and tissue regeneration has been observed in research models.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eStimulation of angiogenesis – a described effect on the formation of new capillaries and local blood supply.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eAnti-inflammatory effect – observed influence on inflammatory mediators and local edema.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eJoint and bone health – a described effect on recovery processes after joint and bone injuries.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eHealing of skin and connective tissue lesions – an effect on the healing of wounds and surgical incisions has been observed in research settings.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eImproved recovery in athletes – faster recovery after exertion has been described in experimental models.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eNeuroprotective potential – an observed role in peripheral nerve regeneration and limitation of neurotoxic damage.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003eAdministration and dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, subcutaneous administration of doses from 0.5mg to 2mg, applied 3 times a week for 4-6 weeks, is most commonly encountered.\u003c\/p\u003e\n\u003cp\u003eFor 5 mg + 3 ml bacteriostatic water: 1.67 mg\/ml → 0.15 ml = 0.25 mg = 250µg\u003c\/p\u003e\n\u003cp\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp\u003e0.15 ml = 250µg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 500µg\u003c\/p\u003e\n\u003cp\u003e0.45 ml = 750µg\u003c\/p\u003e\n\u003cp\u003e0.6 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.75 ml = 1.25 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThymosin Beta-4 has been extensively studied in preclinical settings and in limited clinical trials.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn orthopedic research models, effects on tendon and muscle injury recovery, as well as on osteogenesis and inflammatory processes in joints, have been described.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn cardiological research models, a protective effect in ischemic myocardial damage has been observed, linked to angiogenesis and improved local blood supply.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn dermatological and plastic surgery studies, an effect on the healing of chronic skin wounds, ulcers, and surgical scars has been described.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn neurological research models, a potential effect on nerve cell protection and axon regeneration has been observed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eApplication in Sports\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThymosin Beta-4 is prohibited by WADA for use in professional sports because it can:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eaccelerate recovery after muscle and tendon injuries\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eimprove blood supply and tissue healing\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ereduce recovery time between heavy loads\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eincrease endurance through optimized local circulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eRare and mild reactions have been described in research conditions, such as:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003efatigue\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eheadache\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003edizziness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eredness or pain at the injection site\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eLess commonly, changes in appetite, drowsiness, or slight fluid retention may be observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is gathered and systematized from various scientific sources and studies. It serves \u003c\/span\u003esolely for educational purposes\u003cspan class=\"s1\"\u003e and \u003c\/span\u003eshould not be used for the diagnosis, treatment, or prevention of diseases\u003cspan class=\"s1\"\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53386103947607,"sku":"PP-THYMOSIN-B4-5MG","price":49.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/timozin-beta-4brthymosin-beta-4-5mg-9632338_2d3f8e1a-c921-4ca6-8088-83ed4ff29bce.png?v=1779544796"},{"product_id":"bpc-157-3","title":"BPC-157 5mg\/10mg","description":"\u003ch1 class=\"p1\"\u003eWhat is BPC-157?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eBPC-157 is a pentadecapeptide composed of 15 amino acids. It is a fragment of the body protection compound (BPC) protein complex, originally identified in human gastric juice.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn preclinical studies, BPC-157 has been the subject of significant scientific interest due to its potential role in the processes of muscle, tendon, ligament, and other connective tissue repair. In laboratory models, activity related to organ protective mechanisms and the gastric mucosa has also been described.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn the context of the gastrointestinal system, effects have been observed in models of increased intestinal permeability, inflammatory processes, gastrointestinal spasms, and experimental ulcerations. In separate experimental models, a potential analgesic effect has also been reported.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eUnder laboratory conditions, BPC-157 is associated with processes such as increased collagen and reticulin formation, as well as angiogenesis. Concurrently, macrophage and fibroblast activity has been observed, placing it among compounds investigated in relation to tissue regeneration.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eObservations on BPC-157\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eBPC-157 is considered in scientific literature in connection with the following potential areas of action:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eInjury Healing\u003c\/strong\u003e – observations on tendons, muscles, joints, and bone tissue have been described.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eChronic Inflammatory Processes\u003c\/strong\u003e – a potential role in limiting the inflammatory response is being considered.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eGastrointestinal Protection\u003c\/strong\u003e – support for the mucosa and reduction of ulcerative lesions have been observed.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eCirculation\u003c\/strong\u003e – effects on angiogenesis and local blood supply have been described.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eSurgical Recovery\u003c\/strong\u003e – accelerated tissue regeneration has been observed under experimental conditions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eOrgan Protection\u003c\/strong\u003e – beneficial effects on liver, heart, and nerve tissue have been described in in vivo models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eJoint and Bone Health\u003c\/strong\u003e – effects on cartilage structure and bone repair have been observed.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eAnti-inflammatory Mechanisms\u003c\/strong\u003e – potential for limiting local inflammatory reactions is being investigated.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003e\u003cstrong\u003eRecovery after exertion\u003c\/strong\u003e – faster recovery after physical stress has been described in experimental models.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003e\u003cb\u003eAdministration and Dosage\u003c\/b\u003e\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, subcutaneous administration once daily is most commonly described. The experimental doses used typically range between 250–500 μg (0.25–0.5 mg) daily.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhen dissolving 5 mg with 3 ml of bacteriostatic water:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe resulting concentration is 1.67 mg\/ml, which means that 0.15 ml contains approximately 0.25 mg = 250 μg.\u003c\/p\u003e\n\u003cp\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp\u003e0.15 ml = 250 μg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 500 μg\u003c\/p\u003e\n\u003cp\u003e0.45 ml = 750 μg\u003c\/p\u003e\n\u003cp\u003e0.6 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.75 ml = 1.25 mg\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhen dissolving 10 mg with 3 ml of bacteriostatic water:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe resulting concentration is 3.33 mg\/ml, which means that 0.15 ml contains approximately 0.5 mg = 500 μg.\u003c\/p\u003e\n\u003cp\u003eExample values for 10 mg:\u003c\/p\u003e\n\u003cp\u003e0.15 ml = 500 μg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.45 ml = 1.5 mg\u003c\/p\u003e\n\u003cp\u003e0.6 ml = 2 mg\u003c\/p\u003e\n\u003cp\u003e0.75 ml = 2.5 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eBPC-157 has been primarily investigated in preclinical models, where a wide range of potential physiological effects have been observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn an orthopedic context, observations have been described for accelerated recovery of tendons, ligaments, and muscles, as well as stimulation of osteogenesis in bone injuries.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn gastroenterological models, effects on the gastric and intestinal mucosa have been observed, including reduction of ulcerative lesions, recovery from experimental colitis, and reduction of damage associated with non-steroidal anti-inflammatory drugs.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn cardiological experimental models, protective effects against ischemic myocardial damage have been described, as well as improvements related to angiogenesis and local blood supply.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eNeurological models consider a potential role in supporting peripheral nerve regeneration and limiting neurotoxic damage.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eAdditionally, anti-inflammatory effects have been observed in experimental models of arthritis, including reduction of pain and local edema.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eApplication in Sports\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eBPC-157 is included in the WADA prohibited list for professional sports, as effects related to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eaccelerated tissue recovery after physical exertion\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003einfluence on tendons, joints, and connective tissue\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eeffect on tissue regeneration processes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eimproved adaptation to intense physical exertion\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn preclinical conditions, BPC-157 is described as well-tolerated. Reported reactions are rare, usually mild, and more frequently associated with higher doses.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eDescribed reactions include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003emild stomach discomfort or nausea\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eredness or sensitivity at the application site\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003e\u003cem style=\"font-size: 0.875rem;\"\u003e\u003cspan class=\"s1\"\u003eThis information has been compiled and systematized from various scientific publications and studies. It serves an educational purpose only and should not be used for the diagnosis, treatment, or prevention of diseases.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53386103980375,"sku":null,"price":29.0,"currency_code":"EUR","in_stock":true},{"title":"10mg","offer_id":53386104013143,"sku":"PP-BPC157-10MG","price":49.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/bpc-157br5mg10mg-5909782_b2b5623f-2c10-4be8-a82f-502ea1c3cefb.png?v=1779544797"},{"product_id":"sermorelin","title":"Sermorelin 5mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Sermorelin?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eSermorelin is a synthetic peptide composed of 29 amino acids. It is an analog of the endogenous hormone GHRH (Growth Hormone Releasing Hormone), which stimulates the pituitary gland to secrete its own growth hormone (GH).\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eUnlike the direct administration of recombinant GH, sermorelin supports the natural regulation of secretion, preserving the physiological feedback mechanisms.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003eObservations on Sermorelin\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eSermorelin is being studied for its possible effects on:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eStimulating growth hormone secretion – in research models, an increase in endogenous GH from the pituitary gland has been observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eMuscle mass and strength – an effect on protein and collagen synthesis has been described.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eJoint and bone health – an influence on bone mineralization has been observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eRegeneration and recovery – under experimental conditions, a reduction in recovery time after exertion has been described.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eSleep quality – an observed effect on deep sleep phases.\u003c\/p\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, subcutaneous administration of 100-300 μg once daily is described, usually before sleep, to synchronize with physiological GH pulses.\u003c\/p\u003e\n\u003cp\u003eFor 5 mg + 3 ml bacteriostatic water: 1.67 mg\/ml → 0.06 to 0.18 ml daily\u003c\/p\u003e\n\u003cp\u003eFor 10 mg + 3 ml bacteriostatic water: 3.3 mg\/ml → 0.03 to 0.09 ml daily\u003c\/p\u003e\n\u003cp\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 100μg\u003c\/p\u003e\n\u003cp\u003e0.18 ml = 300 μg\u003c\/p\u003e\n\u003cp\u003e0.15 ml = 250 μg\u003c\/p\u003e\n\u003cp\u003e0.30 ml = 500μg\u003c\/p\u003e\n\u003cp\u003e0.45 ml = 750μg\u003c\/p\u003e\n\u003cp\u003eExample values for 10 mg:\u003c\/p\u003e\n\u003cp\u003e0.03ml = 100μg\u003c\/p\u003e\n\u003cp\u003e0.09ml = 300 μg\u003c\/p\u003e\n\u003cp\u003e0.15 ml = 500 μg\u003c\/p\u003e\n\u003cp\u003e0.30 ml = 1.0 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eSermorelin has been studied in clinical and preclinical settings.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn endocrinology, it has been used for the diagnosis of GH deficiency and as a therapeutic agent to stimulate endogenous growth hormone.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn gerontology and regenerative medicine, it is being investigated for its potential to improve body composition, muscle tone, and bone density.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn sports medicine, there is interest in its effects on recovery and adaptation after exertion.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eApplication in Sports\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eSermorelin is prohibited by WADA for use in professional sports, as it may:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- stimulate growth hormone secretion\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- improve tissue recovery\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- increase muscle mass and strength\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- aid in fat reduction\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn preclinical conditions, adverse reactions are usually rare and mild, including:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- redness or pain at the injection site\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- headache\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- dizziness\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- mild fluid retention\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eLess commonly observed are insomnia or palpitations.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information has been collected and systematized from various scientific sources and studies. It serves \u003c\/span\u003eeducational purposes only\u003cspan class=\"s1\"\u003e and \u003c\/span\u003eshould not be used for the diagnosis, treatment, or prevention of diseases\u003cspan class=\"s1\"\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53386104045911,"sku":"PP-SERMORELIN-5MG","price":59.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/sermorelin-sermorelinbr5mg10mg-2113533_2eb21a45-0060-4364-af55-c9df858579de.png?v=1779544801"},{"product_id":"c-ipamorelin","title":"Ipamorelin 10mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Ipamorelin?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eIpamorelin is a synthetic pentapeptide from the GHRP (Growth Hormone Releasing Peptides) group, which acts as a selective agonist of the ghrelin receptor (GHS-R1a). Its primary action is related to stimulating the pituitary gland to release growth hormone (GH). Unlike other GHRP peptides, Ipamorelin is characterized by a more selective profile and a lower probability of increasing cortisol and prolactin. In scientific literature, it is often described as one of the most balanced and well-tolerated representatives of this group. In research settings, it is being investigated in relation to muscle growth, tissue recovery, bone health, and metabolic processes.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\n\u003ch2\u003eObservations with Ipamorelin\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIpamorelin is being studied in relation to the following physiological processes:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eStimulation of growth hormone – enhances GH pulses without a significant increase in prolactin and cortisol.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eSupport for muscle mass – linked to protein synthesis and anabolic processes.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eImproved recovery – observed role in regeneration after physical exertion.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eJoint and bone health – considered in relation to mineralization and tendon recovery.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eSleep quality – associated with supporting the deep phases of sleep.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eEffects on cellular regeneration – studied in relation to IGF-1 and recovery processes.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eMetabolic action – an observed link to lipolysis and regulation of fat balance.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eCardioprotective effects – in experimental models, a potential protective effect on cardiac function has been described.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIpamorelin has been studied in preclinical models and limited clinical trials.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn endocrinology, it is considered due to reliable GH stimulation without significant changes in ACTH, cortisol, and prolactin levels.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn orthopedics and sports medicine, interest is focused on the recovery of muscles, tendons, and bone structures.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn gerontology, it is being investigated for its potential role in age-related changes associated with muscle mass and bone density loss.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn cardiology and neurology, it is considered a possible protective factor against cellular damage and oxidative stress.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, subcutaneous administration in the range of 200–300 μg daily, divided into 1–3 applications, is most commonly described.\u003c\/p\u003e\n\u003cp\u003eFor 10 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 3.3 mg\/ml → 0.06 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003eExample values for 10 mg:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003e0.12 ml = 400 μg\u003c\/p\u003e\n\u003cp\u003e0.18 ml = 600 μg\u003c\/p\u003e\n\u003cp\u003e0.24 ml = 800 μg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003eApplication in Sports\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIpamorelin is included in WADA's prohibited list for professional sports because it can:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003estimulate growth hormone release\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eaid in tissue recovery\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003epositively influence muscle mass and strength\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eparticipate in fat reduction processes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p2\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIpamorelin is generally considered well-tolerated in clinical studies. Reported reactions are rare and usually mild:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eredness or discomfort at the injection site\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eheadache\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003efatigue or drowsiness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003emild fluid retention\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\u003cp class=\"p1\"\u003eAt higher doses, dizziness or temporary changes in appetite may be observed less frequently.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information has been gathered and systematized from various scientific publications and studies. It serves \u003c\/span\u003esolely for educational purposes\u003cspan class=\"s1\"\u003e and \u003c\/span\u003eshould not be used for the diagnosis, treatment, or prevention of diseases\u003cspan class=\"s1\"\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"10mg","offer_id":53386104635735,"sku":"PP-IPAMORELIN-10MG","price":49.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/ipamorelin-ipamorelinbr10mg-9325709_a80fd981-aa41-4801-b17c-16cd74bfd1d2.png?v=1779544802"},{"product_id":"acjc-1295","title":"CJC-1295 (no DAC) 5mg","description":"\u003ch1\u003eWhat is CJC-1295?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eCJC-1295 (Mod GRF 1-29) is a synthetic analog of Growth Hormone Releasing Hormone (GHRH), composed of 29 amino acids. The modified form, known as Mod GRF 1-29, contains specific amino acid substitutions that enhance its stability and biological activity compared to the original Sermorelin. Published scientific literature describes that CJC-1295 supports the physiological release of growth hormone (GH) by stimulating the pituitary gland, intensifying natural secretion pulses. It is often considered in combination with GHRP peptides, such as Ipamorelin, due to a potential synergistic effect on GH release.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\n\u003ch2\u003eObservations with CJC-1295\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eCJC-1295 (Mod GRF 1-29) is studied in relation to the following physiological processes:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eGrowth Hormone Stimulation – activation of GH pulses and an increase in IGF-1 have been observed in scientific models.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eInfluence on anabolic processes and protein synthesis.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eSupport for joint and bone health – effects on mineralization and recovery of tendons and bones have been described.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eRegeneration and recovery – an observed role in recovery processes after physical exertion.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eSleep quality – associated with supporting deep sleep phases.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eEffects on tissue regeneration – considered in relation to recovery and cell renewal processes.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eMetabolic action – a connection with lipolysis and fat metabolism has been observed in research models.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, subcutaneous administration once daily in the range of 100–300 μg, usually in the evening before sleep, is most commonly described.\u003c\/p\u003e\n\u003cp\u003eFor 5 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 1.67 mg\/ml → 0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003eApproximate values for 5 mg:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003e0.12 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003e0.18 ml = 300 μg\u003c\/p\u003e\n\u003cp\u003e0.24 ml = 400 μg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eCJC-1295 has been the subject of clinical and preclinical studies in various fields.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn endocrinology, it is considered due to its ability to increase GH and IGF-1 levels with good tolerability.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn sports medicine, interest is related to recovery, maintenance of muscle mass, and reduction of adipose tissue.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn gerontology, it is studied for its potential role in maintaining higher levels of GH and IGF-1 with advancing age.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eCombining with GHRP peptides is often considered a more effective approach compared to standalone administration.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003eApplication in Sports\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eCJC-1295 is included in WADA's prohibited list for professional sports as it can:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003estimulate growth hormone release\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eaid in muscle and tendon recovery\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003epositively affect muscle mass and strength\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eparticipate in fat reduction processes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eReported adverse reactions in scientific literature are usually rare and mild in nature:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eredness or discomfort at the injection site\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003efatigue\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eheadache\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003emild fluid retention\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eLess commonly, dizziness or temporary changes in appetite may be observed.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is gathered and systematized from various scientific publications and studies. It serves \u003c\/span\u003esolely for educational purposes\u003cspan class=\"s1\"\u003e and \u003c\/span\u003eshould not be used for the diagnosis, treatment, or prevention of diseases\u003cspan class=\"s1\"\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53386104766807,"sku":"PP-CJC1295-NODAC-5MG","price":45.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/cjc-1295-no-dacbr5mg-2052321_1247463f-acf2-41a5-80a6-f6dff48584af.png?v=1779544802"},{"product_id":"a-ghk-cu","title":"GHK-Cu (Copper Peptide) 100mg","description":"\u003ch1 class=\"p1\"\u003eWhat is GHK-Cu?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eGHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide found physiologically in human plasma, saliva, and urine. It has a high affinity for copper ions (Cu²⁺) and forms a stable bioactive complex involved in various cellular and tissue processes.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eThe GHK-Cu complex was initially identified as a factor related to tissue repair and regeneration, and its concentration in the body was observed to decrease with age. This underlies the increased scientific interest in the peptide in the fields of dermatology, cosmetic science, and regenerative biology.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eGHK-Cu is known for its role in tissue regeneration, wound healing, stimulating collagen and elastin synthesis, as well as its antioxidant and anti-inflammatory properties. In dermatological and cosmetic practice, it is used as an active ingredient in serums, creams, and lotions, and in scientific models, it is also considered for potential systemic effects.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\n\u003ch2\u003eObservations with GHK-Cu\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eGHK-Cu is being studied in connection with numerous biological and physiological processes, including:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eSkin Regeneration – associated with stimulating the synthesis of collagen, elastin, and other structural components of the dermis, as well as improving skin elasticity and density.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eWound Healing – accelerated processes of epithelial and connective tissue repair have been observed, as well as better organization of newly formed extracellular matrix.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eHair Growth – researched in connection with the activation of hair follicles, prolongation of the anagen phase, and improvement of microcirculation in the scalp.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eEffects on Skin Appearance – associated with reducing fine lines, improving skin tone, and overall skin condition.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eAnti-inflammatory Action – shows the ability to modulate local inflammation and reduce oxidative stress in cellular and tissue models.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eOrgan Protection – experimental data are available for protective effects on the liver, lungs, and nervous system in various models of damage.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eImproved Blood Supply – associated with stimulating angiogenesis and improving tissue nutrition.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eRecovery After Surgical Interventions – considered as a factor supporting the healing of surgical wounds and post-traumatic recovery.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eDifferent dosing regimens have been described in the scientific literature depending on the goal and research model, including both subcutaneous and topical application. Total weekly doses in the range of 5–10 mg, divided into 2–3 applications, are most frequently cited.\u003c\/p\u003e\n\u003cp\u003eFor 100 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 33 mg\/ml → 0.1 ml = 3.3 mg\u003c\/p\u003e\n\u003cp\u003eExample values for 100 mg:\u003c\/p\u003e\n\u003cp\u003e0.05 ml = 1.67 mg\u003c\/p\u003e\n\u003cp\u003e0.1 ml = 3.3 mg\u003c\/p\u003e\n\u003cp\u003e0.2 ml = 6.6 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn dermatology, GHK-Cu shows the ability to support the restoration of skin structure, increase collagen synthesis, and improve parameters related to the elasticity and thickness of the dermis. In individual clinical and cosmetic observations, a reduction in wrinkle depth and improvement in skin texture have been reported.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn trichology, effects on stimulating hair follicles, limiting hair loss, and improving scalp condition have been reported, with most of the data originating from preclinical models and limited clinical observations.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn gastroenterology and hepatology, protective effects on liver tissue, reduction of inflammatory markers, and improvement of regenerative capacity have been observed in experimental models.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn neurology, GHK-Cu is being investigated for its potential to limit neurotoxic damage and support nerve tissue recovery, including through the modulation of oxidative stress and inflammatory processes.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eAdditionally, experimental data have been published on the effects of pulmonary regeneration and the limitation of fibrotic processes in various organs.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eReported adverse reactions in clinical models are rare and usually mild, transient, and localized:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eslight redness at the application site\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003etemporary local discomfort or sensitivity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eheadache\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003efatigue\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eLess frequently, changes in skin pigmentation or mild irritation have been described, depending on individual sensitivity and the concentration used.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e\u003cem\u003eThe information is collected and systematized from various scientific publications and studies. It is for educational purposes only and should not be used for the diagnosis, treatment, or prevention of diseases.\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"100mg","offer_id":53386104832343,"sku":"PP-GHKCU-100MG","price":39.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/ghk-cu-skin-glowbr100mg-4384070_9a5d0ca6-b42a-4dfe-bdd8-f9602f9660d9.png?v=1779544804"},{"product_id":"cahexarelin","title":"Hexarelin 2mg\/5mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Hexarelin?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eHexarelin is a synthetic peptide from the GHRP (Growth Hormone Releasing Peptides) family, composed of 6 amino acids. In research models, it has been described as a potent agonist of the ghrelin receptor GHS-R1a, through which it stimulates the pituitary gland to release growth hormone (GH). In published data, Hexarelin is considered a peptide with a more stable structure and more pronounced activity compared to other representatives of the GHRP group. In research settings, it has been studied in relation to muscle growth, tissue regeneration, bone density, and cardioprotective mechanisms.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\n\u003ch2\u003eObservations on Hexarelin\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eHexarelin is being investigated for its possible effects on:\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eStimulation of growth hormone - associated with an increase in GH pulses and an elevation of IGF-1 secretion.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eIncreased muscle mass and strength - considered in connection with protein synthesis and anabolic processes.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eImproved recovery - in research settings, it has been studied for its potential to shorten regeneration time after physical exertion.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eJoint and bone health - investigated in relation to bone mineralization and the recovery of tendons and connective tissues.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eCardioprotective effects - in experimental models, a potential protective effect on the myocardium has been observed.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eAnti-aging properties - in a scientific context, it has been considered for its possible influence on hormonal balance and catabolic processes.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eAn effect on deep sleep phases has also been described in research models.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eFat reduction - in experimental conditions, an influence on lipolysis and metabolic balance has been observed.\u003c\/p\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, subcutaneous administration in the range of 100-300 μg daily has been described, usually divided into 1-2 applications within research protocols.\u003c\/p\u003e\n\n\u003cp\u003eFor 2 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 0.67 mg\/ml → 0.15 ml = 100 μg\u003c\/p\u003e\n\n\u003cp\u003eFor 5 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 1.67 mg\/ml → 0.1 ml = 167 μg\u003c\/p\u003e\n\n\u003cp\u003eExample values for 2 mg:\u003c\/p\u003e\n\u003cp\u003e0.15 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003e0.45 ml = 300 μg\u003c\/p\u003e\n\u003cp\u003e0.6 ml = 400 μg\u003c\/p\u003e\n\n\u003cp\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003e0.12 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003e0.18 ml = 300 μg\u003c\/p\u003e\n\u003cp\u003e0.24 ml = 400 μg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 500 μg\u003c\/p\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eHexarelin has been studied in preclinical and limited clinical models, where a dose-dependent effect on GH and IGF-1 secretion has been observed.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eIn endocrinological studies, Hexarelin has shown a significant impact on increasing GH and IGF-1, with no evidence of rapid exhaustion of receptor sensitivity within the models considered.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eIn cardiological experiments, protective effects have been described in models of ischemic heart injury, as well as a potential improvement in cardiac function.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eIn an orthopedic and regenerative context, data on accelerated recovery of bone, tendon, and connective tissue injuries have been considered.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eIn sports medicine, interest in Hexarelin is related to its anabolic potential, its influence on the GH\/IGF-1 axis, and the possible shortening of recovery time after exertion.\u003c\/p\u003e\n\n\u003cp class=\"p2\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003e\u003cbr\u003e\u003c\/h2\u003e\n\n\u003ch2 class=\"p1\"\u003eApplication in Sports\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eHexarelin is prohibited by WADA for use in professional sports as it can:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003estimulate growth hormone secretion\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eaccelerate tissue recovery\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eincrease muscle mass and strength\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eaid in fat reduction\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp class=\"p2\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eReported adverse reactions in scientific literature are typically dose-dependent and include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eredness, sensitivity, or pain at the injection site\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003efatigue or drowsiness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003emild water retention\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eincreased appetite\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eincreased cortisol and prolactin levels at higher doses\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp class=\"p1\"\u003eLess frequently, in a research context, headaches, dizziness, or transient discomfort are described.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is collected and systematized from various scientific sources and studies. It serves \u003c\/span\u003eeducational purposes only\u003cspan class=\"s1\"\u003e and \u003c\/span\u003eshould not be used for diagnosis, treatment, or prevention of diseases\u003cspan class=\"s1\"\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"2mg","offer_id":53386104897879,"sku":"PP-HEXARELIN-2MG","price":35.0,"currency_code":"EUR","in_stock":true},{"title":"5mg","offer_id":53386104930647,"sku":"PP-HEXARELIN-5MG","price":59.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/kheksarelin-hexarelinbr2mg5mg-1535587_5da77e4e-6acd-40f3-bfb8-ca3220bfb7db.png?v=1779544805"},{"product_id":"vdgfghrp-6","title":"GHRP-6 5mg","description":"\u003ch1\u003eWhat is GHRP-6?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eGHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide from the GHRP peptide group, acting as an agonist of the ghrelin receptor GHS-R1a. In scientific research, this mechanism has been linked to stimulating growth hormone (GH) secretion, as well as a pronounced influence on appetite signals. In published data, GHRP-6 has been described as a stronger stimulator of GH secretion compared to Ipamorelin, but with lower selectivity, as it can also affect cortisol and prolactin levels under certain conditions. In research models, GHRP-6 has been considered in relation to muscle growth, tissue repair, and metabolic processes. Effects on anabolism, bone health, lipolysis, deep sleep, and appetite have also been observed.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\n\u003c!-- Работещо изображение --\u003e\n\n\u003ch2\u003eObservations for GHRP-6\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eGHRP-6 is being investigated for its possible effects on:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eStimulation of growth hormone - activation of GH pulses and changes in IGF-1 levels have been observed\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eAnabolic effect on muscle mass and protein synthesis processes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eImproved recovery - investigated in relation to regeneration after physical exertion\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eJoint and bone health - considered in relation to bone mineralization and connective tissue repair\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eInfluence on lipolytic processes and metabolic regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eStudies on GH secretion with aging\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIn studies, a pronounced appetite-stimulating effect has been described, linked to the activation of ghrelin receptors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, subcutaneous administration in the range of 100-300 μg daily, usually divided into 1-3 applications within research protocols, has been described.\u003c\/p\u003e\n\n\u003cp\u003eFor 5 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 1.67 mg\/ml → 0.15 ml = 250 μg\u003c\/p\u003e\n\n\u003cp\u003eFor 10 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 3.3 mg\/ml → 0.15 ml = 500 μg\u003c\/p\u003e\n\n\u003cp\u003eApproximate values for 5 mg:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003e0.12 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003e0.18 ml = 300 μg\u003c\/p\u003e\n\u003cp\u003e0.24 ml = 400 μg\u003c\/p\u003e\n\n\u003cp\u003eApproximate values for 10 mg:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003e0.12 ml = 400 μg\u003c\/p\u003e\n\u003cp\u003e0.18 ml = 600 μg\u003c\/p\u003e\n\u003cp\u003e0.24 ml = 800 μg\u003c\/p\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn scientific literature, GHRP-6 is among the most studied representatives of the Growth Hormone Releasing Peptides group. It has been described to stimulate \u003cspan class=\"s1\"\u003eendogenous growth hormone (GH) release\u003c\/span\u003e in a \u003cspan class=\"s1\"\u003edose-dependent manner\u003c\/span\u003e, by activating \u003cspan class=\"s1\"\u003eGHS-R1a receptors\u003c\/span\u003e and supporting the physiological pulsatile pattern of GH secretion.\u003c\/p\u003e\n\n\u003cp class=\"p3\"\u003e\u003cspan class=\"s2\"\u003eGHRP-6 has shown the ability to \u003c\/span\u003eincrease GH and IGF-1 levels\u003cspan class=\"s2\"\u003e, while also being considered in relation to \u003c\/span\u003erecovery processes, protein synthesis, and metabolic activity\u003cspan class=\"s2\"\u003e. A characteristic feature of this peptide is its \u003c\/span\u003epronounced effect on appetite\u003cspan class=\"s2\"\u003e, which is explained by the activation of \u003c\/span\u003eghrelin receptors\u003cspan class=\"s2\"\u003e and distinguishes it from other GHRP analogs.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eIn experimental models, it has been observed that GHRP-6 can have a \u003cspan class=\"s1\"\u003eneutral or minimal effect on cortisol and prolactin\u003c\/span\u003e at moderate amounts, while at higher experimental levels these hormones may increase. This makes it a subject of interest in research on \u003cspan class=\"s1\"\u003emetabolic and anabolic processes\u003c\/span\u003e, \u003cspan class=\"s1\"\u003eaging\u003c\/span\u003e, and \u003cspan class=\"s1\"\u003etissue regeneration\u003c\/span\u003e.\u003c\/p\u003e\n\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eApplication in Sport\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eGHRP-6 is prohibited by WADA for use in professional sports, due to its potential role in:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003estimulating growth hormone secretion\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eaccelerating tissue recovery\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003esupporting muscle growth and strength\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ereducing regeneration time after physical exertion\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eincreasing appetite and caloric intake\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eAdverse reactions described in scientific literature are predominantly dose-dependent and may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eredness, sensitivity, or pain at the injection site\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eincreased appetite\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003efluid retention\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003efatigue or drowsiness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp class=\"p1\"\u003eLess commonly reported:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eheadache or dizziness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eincrease in cortisol and prolactin at higher doses\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is gathered and systematized from various scientific sources and studies. It serves \u003c\/span\u003esolely for educational purposes\u003cspan class=\"s1\"\u003e and \u003c\/span\u003eshould not be used for the diagnosis, treatment, or prevention of diseases\u003cspan class=\"s1\"\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53386105160023,"sku":"PP-GHRP6-5MG","price":29.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/ghrp-6br5mg-6213283_249ea8e0-0b30-4eb6-b2f1-2e693cb95c5c.png?v=1779544809"},{"product_id":"dsip-5mg","title":"DSIP (Delta Sleep Inducing Peptide) 5mg","description":"\u003ch1\u003eWhat is DSIP?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eDSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide, first identified in mammalian brain tissue in the 1970s. It is an octapeptide that has been examined in the scientific literature in relation to sleep regulation, stress response, and neuroendocrine homeostasis. In research settings, DSIP has been used as a model compound to study processes related to sleep, cortisol regulation, and adaptation to psychophysiological stress.\u003c\/p\u003e\n\n\u003c!-- Working image --\u003e\n\n\u003cp class=\"p1\"\u003eIn preclinical and clinical observations, DSIP has been studied for its potential involvement in inducing deep, slow-wave sleep, stabilizing circadian rhythms, and limiting excessive cortisol secretion. Some scientific publications also consider DSIP as a co-regulator of other neurohormonal systems, including somatotropin, prolactin, and ACTH, especially in the context of adaptation to physical exertion, overtraining, and chronic stress.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2\u003eObservations of DSIP\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn scientific literature, DSIP has been studied in connection with several main areas:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eImproving sleep quality - associated with easier entry into deep sleep and more stable circadian rhythms\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eRegulation of cortisol levels - considered a potential modulator of stress response and homeostasis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eSupport for neuroendocrine function - participates in the balance of hormonal systems related to sleep and adaptation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eNeuroprotection - antistress and antioxidant effects on the central nervous system are discussed in research models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eStimulation of recovery processes - investigated in models of physical and mental overstrain\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eMood modulation - separate studies examine a potential link with serotonergic regulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, subcutaneous administration once daily in the range of 100-300 μg daily, most often in the evening before sleep, within research protocols has been described. DSIP is used for studying neuroendocrine mechanisms and has no approved therapeutic dose.\u003c\/p\u003e\n\n\u003cp\u003eFor 5 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 1.67 mg\/ml → 0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003eExample values:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003e0.12 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003e0.18 ml = 300 μg\u003c\/p\u003e\n\u003cp\u003e0.24 ml = 400 μg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 500 μg\u003c\/p\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eDSIP has been studied in various scientific fields, including neuroscience, psychoneuroendocrinology, sports physiology, and gerontology.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIn sleep studies, an increase in deep NREM phases and an improvement in overall sleep quality have been observed\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIn stress and fatigue models, reductions in cortisol and improvement in recovery-related indicators have been described\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIn chronic stress, DSIP has been examined in connection with neuroendocrine balance and adaptive response\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIn neurological models, its potential neuroprotective activity against oxidative stress is being investigated\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIn sports physiology, it is analyzed as a factor related to recovery from insufficient or disturbed sleep\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eApplication in Sports and Research Settings\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eDSIP is not intended for use in sports, but in scientific literature, it is discussed due to its possible role in adaptation to load, sleep regulation, and recovery in actively training models. Due to its potential influence on cortisol regulation and recovery processes, DSIP is among the peptides subject to WADA control for professional athletes.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eInvestigated in connection with normalizing sleep in intense training regimes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eConsidered as a possible factor for better adaptation in chronic fatigue\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ePotential synergy with peptides related to the regulation of the GH\/IGF-1 axis is discussed\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn published scientific literature, DSIP is generally described as well-tolerated within research settings. Reported reactions are rare, usually mild, and dependent on the amount used:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eTransient drowsiness or feeling of fatigue after administration\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eMild dizziness or temporary decrease in blood pressure\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eHeadache, hot flashes, or a feeling of relaxation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp class=\"p1\"\u003eAt higher quantities, mild hypotension and a temporary decrease in concentration have been described in individual observations, likely related to the sedative profile of the compound.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e\u003cem\u003eThe information is based on published scientific sources and is purely educational. It is not intended for the diagnosis, treatment, or prevention of diseases.\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53386105454935,"sku":"PP-DSIP-5MG","price":39.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/dsip-delta-sleep-inducing-peptidebr5mg-7647068_f66d56ef-1657-4520-9b5c-94c3c08e887f.png?v=1779544809"},{"product_id":"aasghrp-2","title":"GHRP-2 5mg\/10mg","description":"\u003ch1 class=\"p1\"\u003eWhat is GHRP-2?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eGHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide that acts as an agonist of the ghrelin receptor GHS-R1a. Through this mechanism, it stimulates the pituitary gland to release growth hormone (GH) and is considered one of the early representatives of the GHRP family. In scientific literature, GHRP-2 has been discussed for its role in endogenous GH secretion, anabolic processes, tissue regeneration, and metabolic regulation.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eCompared to GHRP-6, GHRP-2 is described as a more potent stimulator of GH pulses and a more selective representative of this group of peptides. In research models, effects on anabolism, lipolysis, bone health, appetite, and sleep quality have been observed. Due to its activity on ghrelin receptors, GHRP-2 is used as a model compound in studies on the GH\/IGF-1 axis, regenerative processes, and energy balance.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\n\u003ch2\u003eObservations for GHRP-2\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eGHRP-2 is being investigated for its potential effects on:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eStimulation of growth hormone - enhances pulsatile GH release and is associated with increased IGF-1\u003c\/li\u003e\n\u003cli\u003eIncreased muscle mass - linked to activation of protein synthesis and anabolic mechanisms\u003c\/li\u003e\n\u003cli\u003eImproved recovery - studied in connection with regeneration after physical exertion\u003c\/li\u003e\n\u003cli\u003eJoint and bone health - considered a factor associated with mineralization and connective tissue recovery\u003c\/li\u003e\n\u003cli\u003eFat reduction - associated with stimulation of lipolysis and metabolic balance\u003c\/li\u003e\n\u003cli\u003eAnti-aging effects - investigated for its influence on GH secretion with aging\u003c\/li\u003e\n\u003cli\u003eAppetite-stimulating effect - by activating ghrelin receptors, it can influence food intake\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, subcutaneous administration in the range of 100-300 μg daily, typically divided into 1-3 applications within research protocols, has been described.\u003c\/p\u003e\n\n\u003cp\u003eFor 5 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 1.67 mg\/ml → 0.15 ml = 250 μg\u003c\/p\u003e\n\n\u003cp\u003eFor 10 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 3.3 mg\/ml → 0.15 ml = 500 μg\u003c\/p\u003e\n\n\u003cp\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003e0.12 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003e0.18 ml = 300 μg\u003c\/p\u003e\n\u003cp\u003e0.24 ml = 400 μg\u003c\/p\u003e\n\n\u003cp\u003eExample values for 10 mg:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003e0.12 ml = 400 μg\u003c\/p\u003e\n\u003cp\u003e0.18 ml = 600 μg\u003c\/p\u003e\n\u003cp\u003e0.24 ml = 800 μg\u003c\/p\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn scientific literature, GHRP-2 has been studied in both preclinical and clinical models. The peptide has been described to cause a \u003cspan class=\"s1\"\u003edose-dependent increase in growth hormone (GH)\u003c\/span\u003e and \u003cspan class=\"s1\"\u003einsulin-like growth factor-1 (IGF-1)\u003c\/span\u003e through activation of \u003cspan class=\"s1\"\u003eGHS-R1a receptors\u003c\/span\u003e, thereby stimulating endogenous GH release.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eAmong the representatives of the GHRP group, GHRP-2 stands out for its \u003cspan class=\"s1\"\u003ehigh efficacy and good stability\u003c\/span\u003e, which makes it a subject of interest in fields such as \u003cspan class=\"s1\"\u003eendocrinology, gerontology, and sports medicine\u003c\/span\u003e. Some publications note that at higher amounts, a \u003cspan class=\"s1\"\u003emoderate increase in cortisol and prolactin\u003c\/span\u003e may be observed, highlighting the importance of controlled conditions in its experimental use.\u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003e\u003cbr\u003e\u003c\/h2\u003e\n\n\u003ch2 class=\"p1\"\u003eApplication in Sports\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eGHRP-2 is prohibited by WADA for use in professional sports, as it can:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eStimulate growth hormone secretion\u003c\/li\u003e\n\u003cli\u003eAccelerate tissue regeneration processes\u003c\/li\u003e\n\u003cli\u003eAid muscle growth and strength performance\u003c\/li\u003e\n\u003cli\u003eReduce the time required for regeneration after physical exertion\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eAdverse reactions described in scientific literature are usually dose-dependent and include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eRedness, sensitivity, or pain at the injection site\u003c\/li\u003e\n\u003cli\u003eFatigue or drowsiness\u003c\/li\u003e\n\u003cli\u003eIncreased appetite\u003c\/li\u003e\n\u003cli\u003eFluid retention\u003c\/li\u003e\n\u003cli\u003eIncreased levels of cortisol and prolactin at higher doses\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp class=\"p1\"\u003eHeadache, dizziness, or transient discomfort are less commonly reported.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is collected and systematized from various scientific sources and studies. It serves \u003c\/span\u003eeducational purposes only\u003cspan class=\"s1\"\u003e and \u003c\/span\u003eshould not be used for the diagnosis, treatment, or prevention of diseases\u003cspan class=\"s1\"\u003e.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53386105749847,"sku":"PP-GHRP2-5MG","price":29.0,"currency_code":"EUR","in_stock":true},{"title":"10mg","offer_id":53386105782615,"sku":"PP-GHRP2-10MG","price":49.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/ghrp-2br5mg10mg-6602292_96dff64b-ed3e-4106-8be5-9836d5d1e58f.png?v=1779544813"},{"product_id":"aaigf-lr3","title":"IGF-1 LR3 (Long arginine 3) 1mg","description":"\u003ch1\u003eWhat is IGF-1 LR3?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eIGF-1 LR3 (Insulin-Like Growth Factor-1 Long Arg3) is a synthetically modified form of human Insulin-like Growth Factor 1. The molecule contains 83 amino acids and differs from endogenous IGF-1 by replacing the third amino acid position with arginine (Arg3), as well as by an added 13-amino acid sequence in the N-terminal region. These structural changes are associated with a longer biological half-life and lower affinity for IGF-binding proteins. In scientific literature, IGF-1 LR3 has been primarily considered in the context of cell growth, differentiation, and the regulation of protein metabolism.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003eAs a stabilized analogue of IGF-1, IGF-1 LR3 has been used in various experimental models to study its interaction with IGF-1 receptors and the activation of intracellular signaling pathways such as PI3K\/Akt and MAPK\/ERK. These mechanisms are linked to processes like protein synthesis, cell proliferation, tissue regeneration, and metabolic regulation. Due to its extended half-life, described in the range of approximately 20–30 hours, IGF-1 LR3 is often used as a model compound in studies on longer-lasting anabolic and cellular processes.\u003c\/p\u003e\n\n\u003ch1\u003e\u003c!-- Изображение --\u003e\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2\u003eObservations for IGF-1 LR3\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn published scientific and preclinical data, IGF-1 LR3 has been considered in connection with the following:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eCell growth and differentiation – involvement in mitogenic and anabolic processes\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eProtein synthesis – activation of signaling pathways related to hypertrophic mechanisms\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eTissue regeneration – experimental models related to muscles, tendons, and nervous tissue\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eInsulin-like activity – influence on glucose and amino acid transport to cells\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eStudies on metabolic regulation and glucose homeostasis\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eNeuroprotective mechanisms – potential role in maintaining neuronal structure and survival\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, experimental quantities in the range of 20–100 μg daily are found, used in controlled research settings. IGF-1 LR3 is primarily considered in short-term experimental models aimed at evaluating cellular proliferation, anabolic activity, and receptor-mediated signaling.\u003c\/p\u003e\n\n\u003cp\u003eFor 1 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 0.33 mg\/ml → 0.06 ml = 20 μg\u003c\/p\u003e\n\u003cp\u003eApproximate values:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 20 μg\u003c\/p\u003e\n\u003cp\u003e0.15 ml = 50 μg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 100 μg\u003c\/p\u003e\n\n\u003cp\u003eFor 2 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 0.66 mg\/ml → 0.06 ml = 40 μg\u003c\/p\u003e\n\u003cp\u003eApproximate values:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 40 μg\u003c\/p\u003e\n\u003cp\u003e0.15 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 200 μg\u003c\/p\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIGF-1 LR3 has been the subject of preclinical and limited experimental research as a long-acting analog targeting the IGF-1 receptor system.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eIn cellular models, activation of the PI3K\/Akt signaling pathway and increased protein synthesis in myocytes have been described\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eIn experimental conditions, stimulation of hypertrophic processes and reduction of proteolysis have been observed\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eIn neuronal cultures, IGF-1 LR3 is associated with improved cell survival\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eIn tissue models related to injury and recovery, its potential to accelerate regenerative processes has been studied\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eIts mechanism is not related to an increase in GH, but to direct interaction with IGF-1 receptors\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eApplication in Sports and Research Settings\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIGF-1 LR3 is included in the WADA list as a prohibited substance due to its potential anabolic effect. In laboratory and academic settings, the compound is used as a tool to study cell growth, protein metabolism, and signaling cascades related to IGF-1 receptor activity.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eA model for studying anabolic mechanisms without directly increasing GH\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eStudies on muscle regeneration and recovery processes after tissue damage\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eResearch on metabolic regulation, insulin signaling, and nutrient substrate transport\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn the available scientific literature, IGF-1 LR3 is generally described as well-tolerated within experimental conditions. Transient and dose-dependent reactions have been noted:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eLocal redness or discomfort at the site of experimental application\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eMild fatigue or drowsiness\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eHeadache or feelings of weakness at higher experimental quantities\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eReduction in blood sugar in sensitive models or individuals\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp class=\"p1\"\u003eThe described reactions are predominantly transient and depend on the quantity and study conditions. No severe adverse reactions have been reported in published data for controlled research applications.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e\u003cem\u003eThe information is based on scientific literature and is for educational purposes. It does not constitute medical advice and is not intended for diagnosis, treatment, prevention, or use in humans or animals.\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"1mg","offer_id":53386105848151,"sku":"PP-IGF-1-LR3-5MG","price":69.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/1-2_2f7ea207-3d0e-4104-8739-63a173bc50bc.png?v=1779544789"},{"product_id":"axchgh-frag-176-191","title":"hGH frag (176-191) 5mg","description":"\u003ch1\u003eWhat is hGH Frag 176-191?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003ehGH Fragment 176-191 is a synthetic peptide fragment constructed from the amino acid sequence 176-191 of the C-terminal portion of human growth hormone (hGH). This molecule was developed to separately investigate the lipolytic properties attributed to certain segments of GH, without reproducing the full physiological profile of growth hormone. In scientific literature, hGH Frag 176-191 has been considered a model compound for studies on lipolysis, lipid metabolism, and energy balance.\u003c\/p\u003e\n\n\u003c!-- Изображение --\u003e\n\n\u003cp class=\"p1\"\u003eUnlike full-length hGH, hGH Frag 176-191 is not associated with a significant increase in IGF-1 and does not demonstrate the typical growth effects on tissues and organs. Instead, in experimental models, the peptide has been associated with stimulating fatty acid breakdown and limiting lipogenesis processes. Therefore, it is used as a research tool in studying mechanisms related to fat metabolism and metabolic regulation.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\n\u003ch2\u003eObservations on HGH Frag 176-191\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn published scientific literature, HGH Frag 176-191 has been investigated in relation to the following:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eStimulation of lipolysis – aids in the breakdown of fatty acids in adipocyte models\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eInhibition of lipogenesis – associated with limiting the accumulation of new fat deposits\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eRegulation of body weight – considered a potential model for metabolic modulation\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eMaintenance of lean muscle mass – without the pronounced anabolic profile characteristic of full GH\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eReduction of visceral adipose tissue – observed in models related to obesity\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eInsulin sensitivity – effects described in some preclinical studies\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific publications and experimental protocols, amounts in the range of 250-500 μg daily are found, typically administered subcutaneously under controlled research conditions and often divided into 1-2 applications. The peptide is most often considered in short-term research models focused on lipolytic mechanisms. hGH Frag 176-191 is among the more hydrophobic peptides, which may limit its solubility and typically requires using the entire solution.\u003c\/p\u003e\n\n\u003cp\u003eFor 5 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 1.67 mg\/ml → 0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003eExample values:\u003c\/p\u003e\n\u003cp\u003e0.06 ml = 100 μg\u003c\/p\u003e\n\u003cp\u003e0.12 ml = 200 μg\u003c\/p\u003e\n\u003cp\u003e0.18 ml = 300 μg\u003c\/p\u003e\n\u003cp\u003e0.24 ml = 400 μg\u003c\/p\u003e\n\n\u003ch2\u003e\u003c\/h2\u003e\n\n\u003ch2\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eHGH Frag 176-191 has been primarily the subject of preclinical studies, as well as limited clinical observations. The main scientific data described include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eIncreased lipolytic activity in adipocyte cultures and experimental models\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eReduction of total and visceral adipose tissue without significant changes in IGF-1 levels\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eLack of a distinct effect on glucose homeostasis at low experimental quantities\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eAbsence of observed influence on organ and tissue growth\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eImprovements in lipid metabolism and energy efficiency in some preclinical models\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003eApplication in Sports and Research Settings\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eHGH Fragment 176-191 is listed by WADA as a controlled substance and is not permitted for use by professional athletes. In laboratory and academic contexts, the peptide is used to study lipolytic processes, energy metabolism, and models related to metabolic syndrome, obesity, and insulin resistance.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eModel for studying mechanisms related to fat tissue reduction\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eStudies on insulin sensitivity, lipid metabolism, and energy balance\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eInvestigation of potential interaction with other peptides involved in metabolic regulation\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn the available scientific literature, HGH Frag 176-191 is generally described as well-tolerated within research settings. Observed reactions are primarily mild and transient:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eLocal redness or discomfort at the experimental application site\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eMild fatigue or drowsiness\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp class=\"p1\"\u003eHeadache at higher experimental quantities\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp class=\"p1\"\u003eNo serious adverse reactions at research quantities are reported in the published data. The described effects are primarily dose-dependent, temporary, and dependent on the conditions of the specific model.\u003c\/p\u003e\n\n\u003cp class=\"p1\"\u003e\u003cem\u003eThe information is based on scientific literature and is for educational purposes. It does not constitute medical advice and is not intended for diagnosis, treatment, prevention, or use in humans or animals.\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53386106339671,"sku":"PP-HGH-FRAG-5MG","price":35.0,"currency_code":"EUR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/hgh-frag-176-191br5mg-3748012_c7410536-5990-4c10-9435-3a63dfd65ce5.png?v=1779544815"},{"product_id":"melanotan-ii","title":"Melanotan I 10mg","description":"\u003ch1\u003eWhat is Melanotan I?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eMelanotan I is a synthetic peptide from the melanocortin group, representing a linear tridecapeptide and an analogue of α-MSH (α-Melanocyte-Stimulating Hormone). In scientific literature, it has been primarily investigated for its potential role in stimulating melanogenesis, photoprotection, and modulating skin pigmentation. The peptide acts primarily by activating the melanocortin receptor MC1R, with more limited activity toward other melanocortin receptors.\u003c\/p\u003e\n\u003c!-- Изображение --\u003e\n\u003cp class=\"p1\"\u003eOriginally developed as a research analogue of endogenous α-MSH, Melanotan I has been used to study pathways related to skin pigmentation, photoprotective mechanisms, and the response to UV radiation. Subsequently, interest in the peptide has included research into its effects on oxidative stress, inflammatory processes in the skin, and overall phototolerance.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\u003ch2\u003eObservations for Melanotan I\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn scientific research, Melanotan I has been studied in connection with:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eStimulation of melanogenesis – activation of MC1R in melanocytes and increased eumelanin synthesis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ePhotoprotection – potential protective effect against UV-induced skin damage\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eImprovement of phototolerance in models with increased sensitivity to sunlight\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eInvestigation of effects on oxidative stress and inflammatory mediators in the skin\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eModulation of skin tone and pigmentation uniformity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, cited research dosage regimens vary depending on the model (in vitro, animal, or human studies) and the purpose of the study. With subcutaneous administration in a research setting, doses are usually titrated gradually to assess the dynamics of pigmentation and tolerability.\u003c\/p\u003e\n\u003cp\u003eFor 10 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp\u003eConcentration = 3.3 mg\/ml → 0.075 ml ≈ 250 μg\u003c\/p\u003e\n\u003cp\u003eExample calculated values for laboratory purposes:\u003c\/p\u003e\n\u003cp\u003e0.075 ml ≈ 250 μg\u003c\/p\u003e\n\u003cp\u003e0.15 ml ≈ 500 μg\u003c\/p\u003e\n\u003cp\u003e0.3 ml ≈ 1000 μg\u003c\/p\u003e\n\u003cp\u003eSpecific administration schemes in scientific settings are determined according to the protocol design, the type of model, and the research objectives.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eMelanotan I has been studied in preclinical and limited clinical trials, with a specific focus on pigmentation and photoprotective effects.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ePrimarily activates MC1R, leading to increased eumelanin synthesis and a darker phototype in the models studied\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\n\u003cp class=\"p1\"\u003eIn animal models, reduced damage from UV radiation and faster skin recovery after exposure are described\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIn limited human studies, skin darkening and increased phototolerance have been reported\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIts action is not associated with a significant increase in GH or IGF-1 – the effects are independent of growth hormone\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eStable pigmentation levels have been observed for a certain period after cessation of administration in research settings\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn scientific literature, Melanotan I is generally well tolerated, but transient, dose-dependent reactions may occur:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eFacial flushing or a sensation of warmth\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eMild nausea or temporary stomach discomfort\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eHeadache or feeling of fatigue in some models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIncreased skin pigmentation and darkening of existing moles\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eThe effects are usually reversible and resolve after cessation of administration in research settings. Serious adverse reactions are rarely described within the published doses, but long-term safety and effects on skin lesions remain subject to further study.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e This information is based on scientific publications and is purely educational in nature. It is not intended for the diagnosis, treatment, or prevention of diseases and does not constitute medical advice. \u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"10mg","offer_id":53386106405207,"sku":"PP-MELANOTAN1-10MG","price":49.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/melanotan-melanotan-ibr10mg-5045985_126df4ad-dfbe-4a5d-bbfd-ebb109b1f6e7.png?v=1779544817"},{"product_id":"pt-141","title":"PT-141 10mg","description":"\u003ch1\u003eWhat is PT-141 (Bremelanotide)?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003ePT-141, also known as Bremelanotide, is a synthetic peptide from the melanocortin agonist group, developed as an analogue of α-MSH (α-Melanocyte-Stimulating Hormone). In studies, activation of the melanocortin receptors MC3R and MC4R has been observed in the central nervous system, which is associated with the regulation of sexual function, energy balance, and neuroendocrine response.\u003c\/p\u003e\n\u003c!-- Изображение --\u003e\n\u003cp class=\"p1\"\u003ePT-141 differs from Melanotan II in that it primarily targets central neuroregulation rather than peripheral effects such as melanogenesis. In research settings, it has been used as a model to study the neuromodulation of sexual behavior, vasodilation, and the hypothalamic-pituitary axis, as well as for its potential connection to libido and mood.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003eObservations for PT-141\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn scientific literature, PT-141 has been studied in relation to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eRegulation of sexual function - activation of MC4R in the central nervous system\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eNeuromodulation of libido - influence on dopamine and endorphin pathways\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eEffect on vasodilation and blood flow in the sexual organs\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eRegulation of energy balance and appetite\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eStudies of the melanocortin system and its interaction with other neurotransmitters\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ePotential role in adaptation to stress and central fatigue\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003ePT-141 has been studied in preclinical and limited clinical models for its effects on sexual responsiveness and neurochemical mechanisms:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eActivates MC3R and MC4R receptors, leading to stimulation of neuronal pathways associated with libido\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIn living models, it has shown improved sexual motivation and frequency of copulatory behaviors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIn human studies, increased sexual interest and arousal have been observed\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eDoes not directly affect the cardiovascular system or the hormonal levels of GH and IGF-1\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIs being studied as a potential neuromodulator of the hypothalamic-pituitary axis\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn scientific literature, PT-141 doses between 500 and 2000 μg are typically cited, administered subcutaneously, depending on the research model. Due to its central action, effects occur relatively quickly – within 30 to 120 minutes. Studies use both single applications and short series.\u003c\/p\u003e\n\u003cp class=\"p4\"\u003eWith 10 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eConcentration = 3.3 mg\/ml → 0.15 ml = 500 μg\u003c\/p\u003e\n\u003cp class=\"p4\"\u003eExample values:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.15 ml = 500 μg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.30 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.45 ml = 1.5 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.60 ml = 2 mg\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003e\u003cspan class=\"s1\"\u003eIn research settings, PT-141 is considered well-tolerated.\u003c\/span\u003e In published studies, mild and transient reactions have been reported, including:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eslight nausea or dizziness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003etransient increase in blood pressure\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003efacial flushing or feeling of warmth\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003echanges in sexual motivation in experimental models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003efatigue or slight drowsiness after application\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eMost reactions are described as transient, dose-dependent, and resolving within a few hours. No serious adverse effects have been reported at research concentrations.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003eThe information is based on scientific publications and is purely educational. It is not intended for the diagnosis, treatment, or prevention of diseases.\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"10mg","offer_id":53386106700119,"sku":"PP-PT141-10MG","price":49.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/pt-141-bremelanotidebr10mg-1779039_15608a5c-ae64-4a4b-ab7b-74fb471475a2.png?v=1779544818"},{"product_id":"thymosin-alpha-1","title":"Thymosin alpha-1 5mg","description":"\u003ch1\u003eWhat is Thymosin Alpha-1?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eThymosin Alpha-1 (Tα1) is a natural peptide, originally isolated from the thymus gland, consisting of 28 amino acids. In scientific literature, Tα1 has been studied as an immunomodulating agent involved in regulating innate and acquired immune responses. The synthetic analog of the peptide is used in laboratory settings to study mechanisms related to T-cell activation, inflammatory control, and cellular defense.\u003c\/p\u003e\n\u003ch1\u003e\u003c!-- Изображение --\u003e\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eThymosin Alpha-1 is a subject of scientific interest due to its ability to activate T-lymphocytes, enhance the expression of HLA class I antigens, and modulate the production of cytokines such as IL-2 and IFN-γ. In research settings, it has been used as a tool to study cellular immune regulation, antiviral defense, and immune balance in chronic inflammation.\u003c\/p\u003e\n\u003ch2\u003e\u003cbr\u003e\u003c\/h2\u003e\n\u003ch2\u003eObservations on Thymosin Alpha-1\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn scientific literature, Thymosin Alpha-1 has been studied in relation to:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eRegulation of immune response – activation of T-cells and NK-cells\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eEnhancement of cellular immunity – stimulation of cytokine secretion (IL-2, IFN-γ)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eAntiviral activity – studies on the modulation of antiviral mechanisms\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eImmune homeostasis – restoring the balance between Th1 and Th2 responses\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eImproving response to vaccines and immune stimulants\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eInvestigating its role in autoimmune and inflammatory models\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn scientific literature, doses for Thymosin Alpha-1 typically range between 0.8 – 1.6 mg, administered subcutaneously, 2–3 times per week, depending on the scientific study. In preclinical studies, doses are often adjusted to the target immune activation.\u003c\/p\u003e\n\u003cp class=\"p4\"\u003eFor 5 mg + 3 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eConcentration = 1.67 mg\/ml → 0.6 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p4\"\u003eExample values:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e0.6 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e1.2 ml = 2 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThymosin Alpha-1 has been the subject of numerous studies in the field of immunology and cell biology.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIn cell models, it activates T-lymphocytes and increases the expression of CD3 and CD8 markers\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIncreases the secretion of interferon-γ and interleukin-2, key mediators of cellular immunity\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eIn vivo models have shown protection against viral and bacterial agents\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eImproves antioxidant defense and cell resistance to oxidative stress\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eRegulates apoptotic processes and cellular recovery\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003eApplication in Research Settings\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn laboratory research, the peptide is used to study:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eCellular mechanisms of immune activation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eRegulation of inflammatory response and cytokine signaling\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eSynergy with other bioregulatory peptides and immunostimulants\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eDue to its broad action profile, Tα1 is a valuable model for studying the relationship between the immune system, stress, and recovery processes.\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eIn scientific literature, Thymosin Alpha-1 is generally well-tolerated. Reported reactions are rare and mild:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eSlight redness or pain at the injection site\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eTransient fatigue or weakness\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003eHeadache or dizziness at higher doses\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eNo serious adverse reactions have been reported in research applications. Effects are dose-dependent and transient.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003eThe information is based on scientific publications and is for educational purposes only. It is not intended for the diagnosis, treatment, or prevention of diseases.\u003c\/em\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53386106929495,"sku":"PP-THYMOSIN-A1-5MG","price":59.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/timozin-alfa-1-thymosin-alpha-1br5mg-2531193_6bc18ff6-b9a4-4030-bb04-9c8e4cbfe924.png?v=1779544820"},{"product_id":"sdc-tirzepatide","title":"Tirzepatide 5mg\/10mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Tirzepatide?\u003c\/h1\u003e\n\u003cp class=\"p1\"\u003eTirzepatide is a synthetic peptide composed of 39 amino acids. The molecule belongs to the incretin analog group and exhibits dual activity on GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This combined receptor profile is precisely what distinguishes it from classic GLP-1 analogs, which primarily act on a single incretin pathway.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eInitially, Tirzepatide was developed in the context of type 2 diabetes mellitus, but clinical trials have also described a significant effect on body weight reduction. In research models, changes in insulin sensitivity, blood sugar control, body composition, and a number of metabolic and cardiovascular parameters have been observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e \u003c\/p\u003e\n\u003ch2\u003eObservations for Tirzepatide\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eTirzepatide is being investigated for its potential impact on several key metabolic areas:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eBlood sugar control – research and clinical models have observed a reduction in HbA1c and a limitation of glucose spikes.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eWeight reduction – an effect on reducing fat tissue and improving body composition has been described.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eMetabolic health – changes in lipid profile, hepatic steatosis, and other markers associated with metabolic risk have been observed.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eCardiovascular function – reductions in blood pressure and triglycerides have been described in research settings.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eEnergy homeostasis – an effect on appetite, energy balance, fat oxidation, and metabolic regulation has been observed.\u003c\/p\u003e\n\u003cp class=\"p3\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eScientific Data\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eTirzepatide has been the subject of extensive clinical trials, in which it has emerged as an incretin analog with a pronounced effect on glycemic control and body weight.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn patients with type 2 diabetes mellitus, the following has been reported:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- HbA1c reduction by up to 2%\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Weight loss of 10-15%\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Improvement in lipid profile and blood pressure\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eIn people with obesity without diabetes, the following has been observed:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Weight loss of up to 20% over 72 weeks\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Reduction of visceral fat\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- Improvement in cardio-metabolic parameters\u003c\/p\u003e\n\u003cp class=\"p3\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eScientific literature describes once-weekly subcutaneous administration within clinical and research protocols.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eStandard doses: 2.5 mg - initial dose with gradual titration up to 5 mg weekly depending on tolerance and therapeutic effect.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eFor 5 mg + 2 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eConcentration = 2.5 mg\/ml → 0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eExample values for 5 mg:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.1 ml = 250μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.2 ml = 500μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.3 ml = 750μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.5 ml = 1.25 mg\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eFor 10 mg + 2 ml bacteriostatic water:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eConcentration = 5 mg\/ml → 0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003eExample values for 10 mg:\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.1 ml = 500μg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.3 ml = 1.5 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.4 ml = 2 mg\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e0.5 ml = 2.5 mg\u003c\/p\u003e\n\u003cp class=\"p3\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThe most commonly reported reactions in clinical and research data are related to the gastrointestinal tract, especially during periods of dose escalation.\u003c\/p\u003e\n\u003cp class=\"p3\"\u003ePossible side effects are highly dose-dependent and include:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- nausea, vomiting, diarrhea, constipation\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- decreased appetite\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- abdominal discomfort\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eRarer but more serious risks include:\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- pancreatitis\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- gallstone disease with rapid weight reduction\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e- hypoglycemia when combined with other antidiabetic agents\u003c\/p\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is collected and systematized from various scientific sources and studies. It is for educational purposes only and should not be used for diagnosis, treatment, or prevention of diseases.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"PurePeptide","offers":[{"title":"5mg","offer_id":53386107224407,"sku":null,"price":59.0,"currency_code":"EUR","in_stock":true},{"title":"10mg","offer_id":53386107257175,"sku":null,"price":99.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/Tirzepatide5mg_ff19f292-884d-4c41-be46-84615a825b0a.png?v=1779544821"},{"product_id":"12-retatrutide-1","title":"Retatrutide 5mg\/10mg\/30mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Retatrutide?\u003c\/h1\u003e\n\u003cp\u003eRetatrutide is a peptide analog consisting of 42 amino acids, which is a subject of scientific interest mainly in the field of metabolic regulation. A distinctive feature of the molecule is its triple receptor profile – interaction with GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide) and glucagon receptors. This combined activity distinguishes it from classic GLP-1 analogs and places it among the more extensively studied incretin compounds.\u003c\/p\u003e\n\u003cp\u003eIn scientific literature, Retatrutide is primarily discussed in relation to obesity, type 2 diabetes, and other metabolic conditions. Published clinical data describe changes in body weight, glycemic control, and various cardiometabolic indicators in observed participant groups.\u003c\/p\u003e\n\u003cp class=\"p2\"\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eObservations and Data on Retatrutide\u003c\/h2\u003e\n\u003cp\u003eAvailable publications examine Retatrutide in several main areas related to metabolic function, energy balance, and appetite regulation:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGlucose control\u003c\/strong\u003e – clinical studies have described tendencies towards a reduction in HbA1c and an improvement in insulin sensitivity in some participants.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeight reduction\u003c\/strong\u003e – published results show a significant reduction in body weight and fat mass, with effects being more pronounced in some protocols compared to compounds with a dual receptor mechanism.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepatic metabolism\u003c\/strong\u003e – individual studies have reported changes in hepatic steatosis, as well as improvements in some lipid profile indicators.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiometabolic markers\u003c\/strong\u003e – changes in triglycerides, systolic blood pressure, and certain inflammatory markers have been described.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEnergy expenditure\u003c\/strong\u003e – experimental models suggest a possible influence on energy expenditure, utilization of fat stores, and mechanisms related to appetite.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eScientific publications most often describe subcutaneous administration once weekly. Various research protocols use gradual titration, with initial doses often starting at 2 mg weekly and subsequently increasing according to tolerability and observed results.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhen dissolving 5 mg with 2 ml bacteriostatic water:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe resulting concentration is 2.5 mg\/ml, meaning 0.4 ml contains 1 mg.\u003c\/p\u003e\n\u003cp\u003eApproximate values:\u003c\/p\u003e\n\u003cp\u003e0.1 ml = 0.25 mg\u003c\/p\u003e\n\u003cp\u003e0.2 ml = 0.5 mg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 0.75 mg\u003c\/p\u003e\n\u003cp\u003e0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.5 ml = 1.25 mg\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhen dissolving 10 mg with 2 ml bacteriostatic water:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe resulting concentration is 5 mg\/ml, meaning 0.2 ml contains 1 mg.\u003c\/p\u003e\n\u003cp\u003eApproximate values:\u003c\/p\u003e\n\u003cp\u003e0.1 ml = 0.5 mg\u003c\/p\u003e\n\u003cp\u003e0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 1.5 mg\u003c\/p\u003e\n\u003cp\u003e0.4 ml = 2 mg\u003c\/p\u003e\n\u003cp\u003e0.5 ml = 2.5 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003eScientific Publications\u003c\/h2\u003e\n\u003cp\u003eRetatrutide has also been studied in the TRIUMPH-4 clinical trial, phase 3, conducted over 68 weeks in participants with obesity or overweight and concomitant knee osteoarthritis, without diagnosed diabetes.\u003c\/p\u003e\n\u003cp\u003eAccording to the published results, the following trends were observed during the study:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAverage body weight reduction of approximately 28.7% by week 68 in the 12 mg dose group.\u003c\/li\u003e\n\u003cli\u003eSignificant reduction in pain according to the WOMAC scale, combined with improvement in physical function and daily activity.\u003c\/li\u003e\n\u003cli\u003eFavorable changes in non-HDL cholesterol, triglycerides, hsCRP, and systolic blood pressure at higher dose regimens.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003ch2 class=\"p1\"\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp class=\"p1\"\u003eThe most commonly described adverse reactions in scientific literature are related to the gastrointestinal system.\u003c\/p\u003e\n\u003cp class=\"p1\"\u003eThese are typically dose-dependent and may include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003enausea, vomiting, diarrhea, or constipation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003edecreased appetite\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ebloating, feeling of heaviness, and abdominal discomfort\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003eLess frequently, publications also discuss potentially more serious risks, including:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003echolelithiasis, especially with rapid body weight reduction\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp class=\"p1\"\u003ehypoglycemia when combined with antidiabetic therapies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"p1\"\u003e\u003cem\u003e\u003cspan class=\"s1\"\u003eThe information is summarized based on available scientific publications and clinical observations. It is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"PurePeptide","offers":[{"title":"5mg","offer_id":53386107289943,"sku":null,"price":59.0,"currency_code":"EUR","in_stock":true},{"title":"10mg","offer_id":53386107322711,"sku":null,"price":99.0,"currency_code":"EUR","in_stock":true},{"title":"30mg","offer_id":53386107355479,"sku":null,"price":169.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/Reta_5mg.png?v=1779544825"},{"product_id":"a-a-semaglutide","title":"Semaglutide 5mg\/10mg","description":"\u003ch1\u003eWhat is Semaglutide?\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e is a synthetic peptide analog, composed of 31 amino acids, primarily studied as a selective GLP-1 receptor agonist. Semaglutide belongs to the group of incretin analogs and is the subject of numerous scientific publications related to metabolic regulation, blood sugar control, and changes in body weight.\u003c\/p\u003e\n\u003ch2\u003eSemaglutide — Mechanism and Scientific Observations\u003c\/h2\u003e\n\u003cp\u003eIn scientific literature, Semaglutide is discussed in connection with the activation of GLP-1 receptors, which are involved in the regulation of glucose metabolism, appetite, and gastric emptying. The molecule is modified to have an extended half-life, allowing for research with weekly protocols.\u003c\/p\u003e\n\u003cp\u003eIn clinical and experimental observations, Semaglutide has been associated with a reduction in HbA1c, body weight reduction, improvement in lipid profile, and changes in cardio-metabolic parameters. Effects on appetite, energy homeostasis, and visceral fat have also been described.\u003c\/p\u003e\n\u003ch2\u003eScientific Data on Semaglutide\u003c\/h2\u003e\n\u003cp\u003eIn patients with type 2 diabetes, published studies have observed reductions in HbA1c, weight reduction, and improvements in some metabolic markers. In people with obesity without diabetes, average changes in body weight of 12–15% over a period of up to 68 weeks have been described.\u003c\/p\u003e\n\u003cp\u003eSemaglutide continues to be the subject of active scientific research related to metabolic disorders, insulin sensitivity, and cardiovascular parameters. Changes in appetite, caloric intake, and body composition have been observed in various research models.\u003c\/p\u003e\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp\u003eThe most commonly reported reactions to Semaglutide are related to the gastrointestinal tract and include nausea, vomiting, diarrhea, constipation, decreased appetite, and abdominal discomfort. Rarer but more serious risks include pancreatitis, cholelithiasis, and hypoglycemia when combined with other antidiabetic agents.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eThe information is compiled and systematized from scientific sources and serves educational purposes only. It should not be used for diagnosis, treatment, or prevention of diseases.\u003c\/em\u003e\u003c\/p\u003e","brand":"PurePeptide","offers":[{"title":"5mg","offer_id":53386107617623,"sku":null,"price":49.0,"currency_code":"EUR","in_stock":true},{"title":"10mg","offer_id":53386107650391,"sku":null,"price":89.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/Semaglutide_5mg_55bfa366-6dfc-42f3-b518-7a25e8ceb136.png?v=1779544791"},{"product_id":"mots-c","title":"MOTS-c 10mg","description":"\u003ch1 class=\"p1\"\u003eWhat is MOTS-c?\u003c\/h1\u003e\n\u003cp\u003eMOTS-c is a peptide molecule identified by Dr. Ping Ling and a research team from the University of Southern California. It originates from mitochondria—the cellular structures centrally involved in energy production and regulation within the cell.\u003c\/p\u003e\n\n\u003cp\u003eMOTS-c is a relatively new subject of scientific interest and continues to be actively studied to clarify its biological functions more precisely. In published literature, the peptide is considered a mitochondrially-encoded signaling molecule associated with metabolic regulation, energy balance, mitochondrial activity, and cellular adaptation to various stressors.\u003c\/p\u003e\n\n\u003cp\u003eOne of the most frequently discussed aspects of MOTS-c is its role in metabolic control. In experimental models, observations of improved glucose tolerance, increased insulin sensitivity, and influence on cellular mechanisms involved in energy metabolism and metabolic homeostasis have been reported.\u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003eObservations with MOTS-c\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic processes\u003c\/strong\u003e – considered in relation to the regulation of glucose metabolism, cellular energy, and the maintenance of metabolic balance.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eInsulin sensitivity\u003c\/strong\u003e – effects related to better glucose control and improved insulin sensitivity have been described in scientific models.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003ePhysical endurance\u003c\/strong\u003e – publications discuss a potential influence on muscle function, physical activity, and adaptation to exercise.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial activity\u003c\/strong\u003e – MOTS-c participates in cellular signaling processes related to maintaining mitochondrial function.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eCellular stress and inflammation\u003c\/strong\u003e – studied in the context of adaptation to metabolic stress and the modulation of chronic inflammatory processes.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eCognitive function and sleep\u003c\/strong\u003e – in limited observations, a possible link with cognitive indicators, neurometabolic regulation, and sleep quality is considered.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Data\u003c\/h2\u003e\n\u003cp\u003eIn publications related to \u003cem\u003eCell Metabolism\u003c\/em\u003e, MOTS-c has been described as a mitochondrial peptide that can activate key metabolic pathways and participate in the regulation of glucose homeostasis. In experimental models, improvements in metabolic control, physical endurance, and cellular response to energy stress have been observed.\u003c\/p\u003e\n\n\u003cp\u003eFurther research considers MOTS-c as a signaling molecule that can communicate with various cells and tissues. In this context, the peptide is being studied in relation to mitochondrial activity, inflammatory processes, cellular adaptation, and mechanisms associated with aging.\u003c\/p\u003e\n\n\u003ch2\u003ePotential effects discussed in scientific literature\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eImprovement of glucose tolerance\u003c\/li\u003e\n\u003cli\u003eImprovement of insulin sensitivity\u003c\/li\u003e\n\u003cli\u003eSupport of mitochondrial function\u003c\/li\u003e\n\u003cli\u003eIncrease in physical endurance\u003c\/li\u003e\n\u003cli\u003eInfluence on metabolic processes\u003c\/li\u003e\n\u003cli\u003eLimitation of chronic inflammatory processes\u003c\/li\u003e\n\u003cli\u003eImproved adaptation to cellular and metabolic stress\u003c\/li\u003e\n\u003cli\u003ePotential link with cognitive function and sleep quality\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn some scientific sources, MOTS-c is described with exemplary experimental protocols of around 2.5 mg once every 5 days. These data are presented for informational purposes only and do not constitute a recommendation for use.\u003c\/p\u003e\n\n\u003cp\u003eExample concentrations for 10 mg \/ 2 ml solution:\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 1.5 mg\u003c\/p\u003e\n\u003cp\u003e0.4 ml = 2 mg\u003c\/p\u003e\n\u003cp\u003e0.5 ml = 2.5 mg\u003c\/p\u003e\n\u003cp\u003e0.6 ml = 3 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003ePossible side effects\u003c\/h2\u003e\n\u003cp\u003eCurrently, there is insufficient large-scale clinical data to allow a full assessment of the safety profile in humans. In limited observations, mild and transient adverse reactions such as:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eheadache\u003c\/li\u003e\n\u003cli\u003enausea\u003c\/li\u003e\n\u003cli\u003estomach discomfort\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eDue to the limited volume of human data, no definitive conclusions can be drawn regarding long-term safety, optimal quantities, or effectiveness in various conditions.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThe information is summarized based on available scientific publications and is for educational purposes only. It should not be used for diagnosis, treatment, or prevention of diseases.\u003c\/em\u003e\u003c\/p\u003e","brand":"PurePeptide","offers":[{"title":"10mg","offer_id":53408080855383,"sku":null,"price":45.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/MOTS-c_4aea18a0-0bd0-4fb9-b3d4-a92d85a6d26b.png?v=1779544795"},{"product_id":"tesamorelin-10mg","title":"Tesamorelin 10mg","description":"\u003ch1 class=\"p1\"\u003eWhat is Tesamorelin?\u003c\/h1\u003e\n\u003cp\u003eTesamorelin is a synthetic peptide analog of GHRH (Growth Hormone-Releasing Hormone), created to stimulate endogenous growth hormone release by interacting with GHRH receptors in the pituitary gland. Unlike direct growth hormone administration, Tesamorelin acts by activating natural pituitary GH secretion.\u003c\/p\u003e\n\n\u003cp\u003eIn scientific literature, Tesamorelin has been primarily discussed in relation to the regulation of the GH\/IGF-1 axis, visceral adipose tissue, lipid metabolism, and metabolic risk. Its best-documented clinical data are in HIV-associated lipodystrophy, where it has been studied for its effect on abdominal visceral adipose tissue.\u003c\/p\u003e\n\n\u003cp\u003eOne of the most frequently discussed aspects of Tesamorelin is its ability to stimulate pulsatile growth hormone release, which secondarily leads to an increase in IGF-1. In research and clinical models, this has been associated with changes in body composition, lipolysis, fat distribution, and certain indicators of metabolic function.\u003c\/p\u003e\n\n\u003ch2 class=\"p1\"\u003eObservations with Tesamorelin\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGH\/IGF-1 axis\u003c\/strong\u003e – discussed in relation to stimulating endogenous growth hormone release and increasing IGF-1.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eVisceral adipose tissue\u003c\/strong\u003e – in clinical studies, an effect on the reduction of abdominal visceral fat has been described in specific study populations.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eMetabolic processes\u003c\/strong\u003e – studied in relation to lipid profile, energy balance, and fat metabolism regulation.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eHepatic steatosis\u003c\/strong\u003e – in some scientific literature, Tesamorelin has been studied in HIV-associated fatty liver disease and changes in liver fat.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eBody composition\u003c\/strong\u003e – discussed in relation to fat tissue distribution, waist circumference, and changes in the visceral fat compartment.\u003c\/li\u003e\n\n\u003cli\u003e\n\u003cstrong\u003eCellular and hormonal regulation\u003c\/strong\u003e – studied as a model for the relationship between GHRH signaling, GH secretion, IGF-1, and metabolic adaptation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Data\u003c\/h2\u003e\n\u003cp\u003eIn clinical studies, Tesamorelin has been described as a synthetic GHRH analog that stimulates pituitary growth hormone secretion. The increase in GH leads to a secondary increase in IGF-1, which is used as an important marker for the activity of the GH axis.\u003c\/p\u003e\n\n\u003cp\u003eThe most strongly documented data are related to HIV-associated lipodystrophy. In these models, Tesamorelin has been studied for its ability to reduce visceral adipose tissue without acting as a direct replacement for growth hormone. Some studies have described changes in waist circumference, body composition, and certain lipid parameters.\u003c\/p\u003e\n\n\u003cp\u003eAdditional publications discuss Tesamorelin in HIV-associated non-alcoholic fatty liver disease. In this context, the peptide has been studied in relation to liver fat, metabolic regulation, inflammatory processes, and potential influence on fibrotic progression.\u003c\/p\u003e\n\n\u003ch2\u003ePotential effects discussed in scientific literature\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eStimulation of endogenous growth hormone secretion\u003c\/li\u003e\n\u003cli\u003eIncrease in IGF-1 as a marker for GH axis activity\u003c\/li\u003e\n\u003cli\u003eReduction of visceral adipose tissue in certain study populations\u003c\/li\u003e\n\u003cli\u003eInfluence on body composition and abdominal fat distribution\u003c\/li\u003e\n\u003cli\u003eChanges in lipid profile and metabolic indicators\u003c\/li\u003e\n\u003cli\u003eResearch interest in HIV-associated lipodystrophy\u003c\/li\u003e\n\u003cli\u003ePotential link with hepatic steatosis and fatty infiltration\u003c\/li\u003e\n\u003cli\u003eInvolvement in the regulation of energy balance and lipolysis\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eAdministration and Dosage\u003c\/h2\u003e\n\u003cp\u003eIn scientific and clinical literature, Tesamorelin is described with subcutaneous administration within controlled protocols. The most commonly discussed clinical regimens involve once-daily administration, and this data is provided for informational purposes only and does not constitute a recommendation for use.\u003c\/p\u003e\n\n\u003cp\u003eExample concentrations for 5 mg \/ 2 ml solution:\u003c\/p\u003e\n\u003cp\u003e0.2 ml = 0.5 mg\u003c\/p\u003e\n\u003cp\u003e0.4 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.6 ml = 1.5 mg\u003c\/p\u003e\n\u003cp\u003e0.8 ml = 2 mg\u003c\/p\u003e\n\n\u003cp\u003eExample concentrations for 10 mg \/ 2 ml solution:\u003c\/p\u003e\n\u003cp\u003e0.1 ml = 0.5 mg\u003c\/p\u003e\n\u003cp\u003e0.2 ml = 1 mg\u003c\/p\u003e\n\u003cp\u003e0.3 ml = 1.5 mg\u003c\/p\u003e\n\u003cp\u003e0.4 ml = 2 mg\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\n\u003ch2\u003ePossible Side Effects\u003c\/h2\u003e\n\u003cp\u003eIn clinical and research data, Tesamorelin is generally described as well-tolerated, but reactions related to both the injection site and the activation of the GH\/IGF-1 axis may be observed. Reported reactions include:\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eredness, itching, or discomfort at the injection site\u003c\/li\u003e\n\u003cli\u003emuscle or joint pain\u003c\/li\u003e\n\u003cli\u003efluid retention\u003c\/li\u003e\n\u003cli\u003eheadache\u003c\/li\u003e\n\u003cli\u003enumbness or tingling sensation in the extremities\u003c\/li\u003e\n\u003cli\u003eincrease in IGF-1 in sensitive individuals\u003c\/li\u003e\n\u003cli\u003echanges in glucose metabolism in certain at-risk groups\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eDue to its influence on the GH\/IGF-1 axis, in a clinical context, parameters such as IGF-1, glucose, HbA1c, and overall metabolic status are monitored. The data should not be automatically applied to healthy individuals or other populations outside of the specific study groups.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eThe information is summarized based on available scientific publications and is for educational purposes only. It should not be used for diagnosis, treatment, or prevention of diseases.\u003c\/em\u003e\u003c\/p\u003e","brand":"Store","offers":[{"title":"10mg","offer_id":53618489131351,"sku":null,"price":59.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/files\/Tesamorelin_8c44169b-0e78-4605-ba6e-62b1f340ea5c.png?v=1779544834"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1011\/8902\/6135\/collections\/vsichki-9745208_b6d44d1d-7bde-4584-93a6-98bf79eda379.jpg?v=1779544788","url":"https:\/\/purepeptide.eu\/collections\/1all-the-peptides.oembed","provider":"PurePeptide","version":"1.0","type":"link"}